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Gleaming facilities
and expensive
equipment are now
a necessity, but the
most important in-
gredient for produc-
tive and effective
translational re-
search is the novel
idea and the tenac-
ity in carrying out
the necessary experi-
ments until the an-
swer is obtained.
. . . inspiration of
Andreas Gruentzig,
who translated sim-
ple but elegant ex-
periments into the
foundation for the
field of interven-
tional cardiology,
inspired all of us
and continues to
inspire young physi-
cians and scientists.DITOR’S PAGE
ranslational Research: Then and Now
was recently clearing out some old files belonging to Dr. Keith Robinson, our former transla-
ional research chief scientist. Keith died prematurely last year and his widow brought the files
o me. They were mostly drawers of photographs of old histology, histochemistry, and electron
icroscopy images from the 1980s. Looking at these brought back memories of small rooms
n the basement of the Woodruff research building at Emory University that passed for our
nterventional cardiology research laboratory. The resources were meager but the ideas were
ich. Many of the slides were of balloon-injured porcine coronary artery segments from
ultiple experiments aimed at attempting to control restenosis. These serial histology
pecimens convinced us that the process of restenosis was one of cell growth, not primarily
thrombotic problem as had been previously purported. The scientists and technicians
orking in this cramped space helped illuminate the mechanisms of restenosis through
ollaborations with vascular biologists using in situ hybridization and other techniques.
ystemic drugs did little for preventing restenosis, and local delivery compounds using a
orous balloon developed in our lab were hampered by the inability of the drugs to dwell
ong enough to produce the desired effect. Early stent experiments solved acute recoil but
xaggerated cell growth. Radiation therapy applied intracoronary was an idea based on the
uccess of treating keloid scars on the skin and pterygium on the cornea. This technique
ecame the first local delivery method to effectively inhibit restenosis and pave the way for
ntimitotic drugs applied to stents. Many other ideas were tested and the concept of trans-
ational research applied to interventional cardiology problems was a valuable component
f training for fellows. Some work was sponsored by the industry’s needs to test devices
nd therapies, but much was supported by philanthropy especially from the Rich Founda-
ion, a beneficiary of the venerable Atlanta department store of the same name. We named
he lab for the foundation (Fig. 1).
Some who explored ideas in the Rich Research Laboratory were: Steve Karas and Ed
antoian (the mechanisms of restenosis); Brad Burke (systemic antioxidant therapy for
estenosis); Neal Scott and Steve Hanson (local drug delivery with the porous balloon and
aminar flow techniques); Gary Roubin (the earliest stent evaluations); Ron Waksman
radiation brachytherapy); Nicolas Chronos (antiplatelet therapies in percutaneous coronary
ntervention and stenting); and Cy Wilcox (in situ hybridization techniques). Keith Robinson’s
ollaborators, including Gus Cippola, Norman Tarazona, Gilberto Nunez, Joe Brown, Stefan
erheye, and many others, are among those who made major contributions.
As I move these boxes to the new translational research facility, the Saint Joseph’s
ranslational Research Institute, which evolved from the Emory facility, I am struck by the
ontrasts and similarities between this ultramodern facility and our first research lab. Instead of
rooms and a barely functioning semi-discarded fluoroscopic system, the new institute,
irected by Dr. Nicolas Chronos, is a 38,000-square-foot facility adjacent to the Georgia Tech
ampus, a major center for bioengineering. The senior scientists, veterinarians, and technicians,
ow numbering almost 60, perform pre-clinical experiments to support Food and Drug
dministration applications as well as investigator-initiated experiments in vascular healing,
hrombosis and reactivity, tissue engineering, regenerative medicine, device development and
valuation, and many related fields. Catheterization laboratories, operating bays for large and
mall animals, histology and histochemistry laboratories, specialized instruments including
ntravascular ultrasound, virtual histology, flow cytometry, optical coherence tomography,
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1166ngioscopy, and magnetic resonance imaging, as well as
ecovery and holding bays for more than 100 large animals
Figure 1. The Rich Research Lab in the Late 1980s
From left: Keith A. Robinson, Gilberto Nunez, Joel Goldberg (The Rich Foun-
dation), and Spencer B. King III.rovide the resources for modern science in a spotless good saboratory practice environment. It is a far cry from the
imited facilities we had in the 1980s. The rewards of
articipating in the testing of interesting concepts,
owever, were no less then than now. Gleaming facilities
nd expensive equipment are now a necessity, but the
ost important ingredient for productive and effective
ranslational research is the novel idea and the tenacity in
arrying out the necessary experiments until the answer is
btained.
The inspiration of Andreas Gruentzig, who translated
imple but elegant experiments into the foundation for
he field of interventional cardiology, inspired all of us
nd continues to inspire young physicians and scientists.
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